Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 150 clinical trials
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer

study are: ALRN-6924 Cytarabine (for patients with leukemia only)

chemotherapy regimen
mitomycin
hydroxyurea
TP53
cns tumor
  • 60 views
  • 28 Jun, 2021
  • 3 locations
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL

: Venetoclax Standard Chemotherapy (which includes cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate, 6-mercaptopurine, etoposide, and cytarabine

etoposide
cytarabine
lymphoid leukemia
cyclophosphamide
mercaptopurine
  • 3 views
  • 17 Aug, 2021
  • 2 locations
Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Na ve AML

> Venetoclax Daunorubicin Cytarabine

secondary acute myeloid leukemia
venetoclax
cytarabine
hydroxyurea
daunorubicin
  • 6 views
  • 14 Nov, 2021
  • 1 location
Efficacy and Pharmacogenomics of Salvage CLAG-M Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia

, Cytarabine, Mitoxantrone, G-CSF (CLAG-M) chemotherapy and followed at periodic intervals to determine the primary and secondary objectives.

mitoxantrone
secondary acute myeloid leukemia
hemolysis
colony stimulating factor
cytarabine
  • 52 views
  • 09 Apr, 2021
  • 1 location
Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell and Indolent B-Cell Lymphomas

The investigators hypothesize that duvelisib maintenance after autologous stem cell transplant with carmustine, etoposide, cytarabine, and melphalan (BEAM) conditioning in patients with T-cell

large cell lymphoma
etoposide
cytarabine
carmustine
autograft
  • 0 views
  • 28 Jun, 2021
  • 1 location
Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML

myeloid leukemia. This study involves the following: Venetoclax and decitabine (investigational combination) Cytarabine and idarubicin (per standard of care)

  • 0 views
  • 18 Jan, 2022
  • 1 location
Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old

A phase I-II trial based on the combination of three drugs regimen LDAC or Azacitidine + Venetoclax + Quizartinib that in this population could be well tolerated by a sequential type administration. The first objective is to achieve rapid control of the disease, using two different schemes, one based in …

azacitidine
ejection fraction
venetoclax
cytarabine
  • 0 views
  • 25 May, 2021
  • 15 locations
CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old

This phase II trial studies how well liposome-encapsulated daunorubicin-cytarabine (CPX-351) works in treating patients with secondary acute myeloid leukemia who are younger than 60 years old

secondary acute myeloid leukemia
cytarabine
daunorubicin
myeloid leukemia
chronic myelomonocytic leukemia
  • 0 views
  • 03 Nov, 2021
  • 2 locations
Quizartinib and High-dose Ara-C Plus Mitoxantrone in Relapsed/Refractory AML With FLT3-ITD

In this multicenter, upfront randomized phase II trial, all patients receive quizartinib in combination with HAM (high-dose cytarabine, mitoxantrone) during salvage therapy. Efficacy is assessed

  • 0 views
  • 28 Jan, 2021
  • 1 location
PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years

same. While there is broad agreement in terms of induction chemotherapy using a combination of cytarabine with anthracycline, the choice of chemotherapy regimen is controversial postremisin

cytarabine
anthracyclines
minimal residual disease
induction chemotherapy
residual tumor
  • 12 views
  • 29 Mar, 2021
  • 1 location